Axogen Inc vs Nuwellis Inc — how do they compare? Axogen Inc trades at $48.21 (market cap $2.61B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Axogen Inc is far larger — about 4808.4× Nuwellis Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | NUWE | |
|---|---|---|
Market Cap | $2.61B | $542.80K |
Sector | Technology | Technology |
52-Week High | $48.48 | $220.50 |
52-Week Low | $14.16 | $1.42 |
Enterprise Value | $2.52B | -$1.27M |
Trailing returns across standard periods
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →